L-Carnitine in MCADD audit/UK experience
Up to Metabolic Pharmacists Forum

Dear all,
Here in Bristol the consultants are interested in L-carnitine supplementation in MCADD. Currently its use is controversial and there are no consitent findings in publications.
I have looked at all our patients with MCADD in the South west known to the metabolic team in Bristol (n=35) and found that 37 % of these patients recieve L-carnitine. (I have more results and conclusions that I am happy to share if anyone is interested.)
Obviously, this is a single centre experience of carnitine supplementation in MCADD but we are keen to know what is happening in other IMDs centres in the UK. This will provide us with a multi-centre/national insight into the matter. Furthermore, we spend a substantial amount of levocarnitine, which may not actually be necessary for MCADD patients so may give some weight to a potential cost saving?
I was wondering if anyone would like to participate/get involved. I am happy to share the data/spreadsheets I have here in Bristol to help and if it ends up being a poster etc for co-authors. Feel free to comment on anything that could be improved or think is unnecessary.
Look forward to hearing from you.
Thanks,
Will
(Bristol Children's)